Questions Surround FDA's Orphan Drug Exclusivity Approach
By Jacqueline Berman and Nikita Bhojani · February 2, 2023, 6:31 PM EST
On Jan. 24, the U.S. Food and Drug Administration issued a notice to clarify orphan drug exclusivity following the U.S. Court of Appeals for the Eleventh Circuit's 2021 ruling in Catalyst...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login